Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Healthy Subjects”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Not applicableNot Yet RecruitingNCT07521982
What this trial is testing

Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy Volunteers

Who this might be right for
MULTIPL SCLEROSİS
Baskent University 782
Early research (Phase 1)Study completedNCT04570670
What this trial is testing

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC 50
Not applicableStudy completedNCT02504840
What this trial is testing

Natural History of Multiple Sclerosis and Its Mimickers

Who this might be right for
Neurologic DisordersHealthy VolunteersMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 104
Early research (Phase 1)Study completedNCT06117020
What this trial is testing

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

Who this might be right for
Muscle SpasticityHypertonia, MuscleCerebral Palsy+5 more
Motric Bio 89
Early research (Phase 1)Study completedNCT02474134
What this trial is testing

Comparison Study of PF530 and Betaferon in Healthy Subjects

Who this might be right for
Multiple Sclerosis
Pfenex, Inc 12
Not applicableStudy completedNCT06528665
What this trial is testing

Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects

Who this might be right for
Multiple SclerosisUlcerative Colitis
Corium Innovations, Inc. 24
Early research (Phase 1)Not Yet RecruitingNCT04667013
What this trial is testing

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

Who this might be right for
Healthy
Guangzhou Magpie Pharmaceuticals Co., Ltd. 16
Testing effectiveness (Phase 2)Looking for participantsNCT07085507
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients

Who this might be right for
Multiple Sclerosis
Vidya Therapeutics Inc 100
Early research (Phase 1)Ended earlyNCT05064436
What this trial is testing

Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Bristol-Myers Squibb 10
Early research (Phase 1)Ended earlyNCT02048358
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

Who this might be right for
Healthy VolunteersMultiple Sclerosis
BBB-Therapeutics B.V. 47
Early research (Phase 1)Study completedNCT01326715
What this trial is testing

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 17
Not applicableStudy completedNCT02463318
What this trial is testing

The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects

Who this might be right for
Multiple SclerosisOxidative Stress
Tehran University of Medical Sciences 34
Post-approval studies (Phase 4)Study completedNCT00913666
What this trial is testing

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 121
Early research (Phase 1)Study completedNCT01610310
What this trial is testing

Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

Who this might be right for
HealthyMultiple Sclerosis
Biogen 55
Early research (Phase 1)Study completedNCT02269930
What this trial is testing

Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 30
Testing effectiveness (Phase 2)Looking for participantsNCT05395624
What this trial is testing

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Parkinson Disease (PD)Alzheimer Disease (AD)+1 more
Ashvattha Therapeutics, Inc. 65
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Early research (Phase 1)Study completedNCT06975605
What this trial is testing

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

Who this might be right for
Tuberous Sclerosis Complex (TSC)Focal Cortical DysplasiaOther Neurological Disorders
GRIN Therapeutics, Inc. 18
Early research (Phase 1)Study completedNCT05131971
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants

Who this might be right for
Multiple SclerosisColitis, Ulcerative
GlaxoSmithKline 54
Early research (Phase 1)Study completedNCT02515695
What this trial is testing

Phase I BP Interferon (IFN) Beta-001

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Centre Hospitalier Universitaire Vaudois 12
Next Page